We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

72 hedge funds and large institutions have $543M invested in Loxo Oncology, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 16

13% more capital invested

Capital invested by funds: $479M → $543M (+$64.2M)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1% less funds holding

Funds holding: 73 → 72 (-1)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
34
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$42.1M
2
PC
Paulson & Co
New York
+$12.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.2M
4
OM
Opaleye Management
Massachusetts
+$2.88M
5
AG
Artal Group
Luxembourg
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$13.2M
2
O
OrbiMed
New York
-$11.7M
3
EI
EAM Investors
California
-$3M
4
Axa
Axa
France
-$1.61M
5
Ameriprise
Ameriprise
Minnesota
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASP
51
Adams Street Partners
Illinois
$314K +$313K +11,976 New
VEA
52
Virtus ETF Advisers
New York
$268K – – –
AllianceBernstein
53
AllianceBernstein
Tennessee
$254K +$23.5K +900 +10%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$252K +$1.13K +43 +0.4%
HLA
55
Hamilton Lane Advisors
Pennsylvania
$238K +$238K +9,089 New
AIG
56
American International Group
New York
$201K +$288 +11 +0.1%
BA
57
BlackRock Advisors
Delaware
$183K +$46.8K +1,790 +34%
Wells Fargo
58
Wells Fargo
California
$172K +$49K +1,874 +40%
Morgan Stanley
59
Morgan Stanley
New York
$155K +$9.92K +379 +7%
BG
60
BlackRock Group
United Kingdom
$146K +$13K +495 +10%
Barclays
61
Barclays
United Kingdom
$76K +$6.02K +230 +9%
Bank of America
62
Bank of America
North Carolina
$74K +$2.96K +113 +4%
UBS Group
63
UBS Group
Switzerland
$44K +$30.9K +1,181 +244%
BlackRock
64
BlackRock
New York
$41K +$22.3K +851 +119%
Legal & General Group
65
Legal & General Group
United Kingdom
$34K – – –
Citigroup
66
Citigroup
New York
$30K -$6.49K -248 -18%
Canada Life
67
Canada Life
Manitoba, Canada
$26K – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$24.6K +$10.1K +387 +70%
AIM
69
Advantage Investment Management
Iowa
$8K – – –
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$2K – – –
TCIM
71
TIAA CREF Investment Management
New York
$1.04K +$8.56K +327 +0.8%
Ameriprise
72
Ameriprise
Minnesota
– -$1.38M -59,357 Closed
BCM
73
Bridgeway Capital Management
Texas
– -$701K -30,250 Closed
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
– -$648K -27,964 Closed
PPA
75
Parametric Portfolio Associates
Washington
– -$381K -16,457 Closed
1 2
3
4

LOXO Hedge Fund Activity: Q3 2016 in Review

72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2016, worth a combined $543M — up 13% from $479M a quarter earlier.

Fund positioning in LOXO was balanced in Q3 2016: 8 funds opened new positions, 8 closed out, 34 added to existing stakes and 16 trimmed.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $42.1M. The largest seller was NEA Management Company, cutting an estimated $13.2M.

  • 72 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $543M of Loxo Oncology, Inc stock for Q3 2016, up 13% quarter-over-quarter.
  • 8 funds opened new Loxo Oncology, Inc positions in Q3 2016 and 8 closed out, a net change of 0 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2016 was Victory Capital Management, an estimated $42.1M added.
  • The largest Loxo Oncology, Inc seller in Q3 2016 was NEA Management Company, an estimated $13.2M sold.

Based on aggregated 13F filings for Q3 2016.